Theratechnologies Stock Price

-0.18 (-4.42%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Theratechnologies Inc THTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.18 -4.42% 3.89 17:12:22
Open Price Low Price High Price Close Price Prev Close
4.03 3.90 4.16 3.92 4.07
Bid Price Ask Price Spread News
3.85 3.90 0.05 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
816 192,289 $ 3.96 $ 760,557 - 1.83 - 4.4599
Last Trade Time Type Quantity Stock Price Currency
19:27:05 25 $ 3.90 USD


Draw Mode:

Theratechnologies Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 369.34M 94.95M 94.22M $ 67.84M $ -23.12M - -12.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Theratechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical THTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.604.45993.463.99759,9460.298.06%
1 Month3.584.45993.463.92253,5350.318.66%
3 Months3.894.45993.183.70193,1270.000.0%
6 Months3.664.45993.183.69157,8470.236.28%
1 Year2.214.45991.833.03265,5901.6876.02%
3 Years3.794.45991.332.82208,6760.102.64%
5 Years3.794.45991.332.82208,6760.102.64%

Theratechnologies Description

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.